Aperio Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $61K | Sell |
21,953
-88
| -0.4% | -$245 | ﹤0.01% | 2401 |
|
|
2020
Q3 | $55K | Buy |
22,041
+481
| +2% | +$1.2K | ﹤0.01% | 2352 |
|
|
2020
Q2 | $293K | Buy |
21,560
+3,329
| +18% | +$45.2K | ﹤0.01% | 2036 |
|
|
2020
Q1 | $138K | Buy |
18,231
+7,863
| +76% | +$59.5K | ﹤0.01% | 2162 |
|
|
2019
Q4 | $66K | Sell |
10,368
-4,015
| -28% | -$25.6K | ﹤0.01% | 2288 |
|
|
2019
Q3 | $56K | Buy |
14,383
+7,901
| +122% | +$30.8K | ﹤0.01% | 2277 |
|
|
2019
Q2 | $31K | Buy |
+6,482
| New | +$31K | ﹤0.01% | 2618 |
|